SEARCH

SEARCH BY CITATION

References

  • Almeida L, Soares-da-Silva P. (2004) Safety, tolerability, and pharmacokinetic profile of BIA 2-093, a novel putative antiepileptic, in a rising multiple-dose study in young healthy humans. J Clin Pharmacol44:906918.
  • Almeida L, Falcao A, Maia J, Mazur D, Gellert M, Soares-da-Silva P. (2005) Single-dose and steady-state pharmacokinetics of eslicarbazepine acetate (BIA 2-093) in healthy elderly and young subjects. J Clin Pharmacol45:10621066.
  • Almeida L, Minciu I, Nunes T, Butoianu N, Falcao A, Magureanu SA, Soares-da-Silva P. (2008a) Pharmacokinetics, efficacy, and tolerability of eslicarbazepine acetate in children and adolescents with epilepsy. J Clin Pharmacol48:966977.
  • Almeida L, Potgieter JH, Maia J, Potgieter MA, Mota F, Soares-da-Silva P. (2008b) Pharmacokinetics of eslicarbazepine acetate in patients with moderate hepatic impairment. Eur J Clin Pharmacol64:267273.
  • Almeida L, Bialer M, Soares-da-Silva P. (2009) Eslicarbazepine Acetate. In Shorvon S, Perucca E, Engel J (Eds) The treatment of epilepsy, Blackwell Publishing, Oxford, pp. 485498.
  • Ambrosio AF, Silva AP, Araujo I, Malva JO, Soares-da-Silva P, Carvalho AP, Carvalho CM. (2000) Neurotoxic/neuroprotective profile of carbamazepine, oxcarbazepine and two new putative antiepileptic drugs, BIA 2-093 and BIA 2-024. Eur J Pharmacol406:191201.
  • Ambrosio AF, Soares-Da-Silva P, Carvalho CM, Carvalho AP. (2002) Mechanisms of action of carbamazepine and its derivatives, oxcarbazepine, BIA 2-093, and BIA 2-024. Neurochem Res27:121130.
  • Araujo IM, Ambrosio AF, Leal EC, Verdasca MJ, Malva JO, Soares-da-Silva P, Carvalho AP, Carvalho CM. (2004) Neurotoxicity induced by antiepileptic drugs in cultured hippocampal neurons: a comparative study between carbamazepine, oxcarbazepine, and two new putative antiepileptic drugs, BIA 2-024 and BIA 2-093. Epilepsia 45149:81505.
  • Barcs G, Walker EB, Elger CE, Scaramelli A, Stefan H, Sturm Y, Moore A, Flesch G, Kramer L, D’Souza J. (2000) Oxcarbazepine placebo-controlled, dose-ranging trial in refractory partial epilepsy. Epilepsia41:15971607.
    Direct Link:
  • Benes J, Parada A, Figueiredo AA, Alves PC, Freitas AP, Learmonth DA, Cunha RA, Garrett J, Soares-da-Silva P. (1999) Anticonvulsant and sodium channel-blocking properties of novel 10,11- dihydro-5H-dibenz[b,f]azepine-5-carboxamide derivatives. J Med Chem42:25822587.
  • Ben-Menachem E, Gabbai AA, Hufnagel A, Maia J, Almeida L, Soares-da-Silva P. (2010) Eslicarbazepine acetate as adjunctive therapy in adult patients with partial epilepsy. Epilepsy Res89:278285.
  • Elger C, Bialer M, Cramer JA, Maia J, Almeida L, Soares-da-Silva P. (2007) Eslicarbazepine acetate: a double-blind, add-on, placebo-controlled exploratory trial in adult patients with partial-onset seizures. Epilepsia48:497504.
  • Elger C, Halasz P, Maia J, Almeida L, Soares-da-Silva P. (2009) Efficacy and safety of eslicarbazepine acetate as adjunctive treatment in adults with refractory partial-onset seizures: a randomized, double-blind, placebo-controlled, parallel-group phase III study. Epilepsia50:454463.
  • Falcao A, Maia J, Almeida L, Mazur D, Gellert M, Soares-da-Silva P. (2007) Effect of gender on the pharmacokinetics of eslicarbazepine acetate (BIA 2-093), a new voltage-gated sodium channel blocker. Biopharm Drug Dispos28:249256.
  • Faught E, Limdi N. (2009) Oxcarbazepine. In Shorvon S, Perucca E, Engel J (Eds) The treatment of epilepsy, Blackwell Publishing, Oxford, pp. 575584.
  • Gabbai AA, Ben-Menachem E, Maia J, Almeida L, Soares-da-Silva P. (2008) Long-term treatment of partial epilepsy with eslicarbazepine acetate (ESL): results of a one-year open-label extension of study BIA-2093-302. Epilepsia49(Suppl. 7):432433.
  • Gil-Nagel A, Lopes-Lima J, Almeida L, Maia J, Soares-da-Silva P. (2009) Efficacy and safety of 800 and 1200 mg eslicarbazepine acetate as adjunctive treatment in adults with refractory partial-onset seizures. Acta Neurol Scand120:281287.
  • Hainzl D, Parada A, Soares-da-Silva P. (2001) Metabolism of two new antiepileptic drugs and their principal metabolites S(+)- and R(-)-10,11-dihydro-10-hydroxy carbamazepine. Epilepsy Res44:197206.
  • Halasz P, Cramer JA, Hodoba D, Czlonkowska A, Guekht A, Maia J, Elger C, Almeida L, Soares-da-Silva P. (2010) Long-term efficacy and safety of eslicarbazepine acetate: results of a 1-year open-label extension study in partial-onset seizures in adults with epilepsy. Epilepsia51:19631969.
  • Hebeisen S, Brady K, Konrad D, Soares-da-Silva P. (2011) Inhibitory effects of eslicarbazepine acetate and its metabolites against neuronal voltage-gated sodium channels. Epilepsia52:257258.
  • Lopes-Lima JG-NA, Maia J, Almeida L, Soares-da-Silva P. (2008) Long-term treatment of partial epilepsy with eslicarbazepine acetate (ESL): results of a one-year open-label extension of study BIA-2093-303. Epilepsia49(Suppl. 7):441442.
  • Maia J, Almeida L, Falcão A, Soares E, Mota F, Potgieter JH, Potgieter MA, Soares-da-Silva P. (2008) Effect of renal impairment on the pharmacokinetics of eslicarbazepine acetate. Int J Clin Pharmacol Ther46:119130.
  • Milovan D, Almeida L, Romach MK, Nunes T, Rocha JF, Sokowloska M, Sellers EM, Soares-da-Silva P. (2010) Effect of eslicarbazepine acetate and oxcarbazepine on cognition and psychomotor function in healthy volunteers. Epilepsy Behav18:366373.
  • Perucca E, Falcao A, Maia J, Almeida L, Soares-da-Silva P. (2009) Pharmacokinetics of eslicarbazepine acetate at steady-state in adults with epilepsy. Epilepsia50(Suppl. 4):196.
  • Pires N, Palma N, Loureiro AI, Bonifacio MJ, Wright LC, Soares-da-Silva P. (2011) Effects of eslicarbazepine acetate, eslicarbazepine, carbamazepine and oxcarbazepine in the maximal electroconvulsive shock test in the mice. Epilepsia52(Suppl. 6):118.
  • Schmidt D, Sachdeo R. (2000) Oxcarbazepine for treatment of partial epilepsy: a review and recommendations for clinical use. Epilepsy Behav1:396405.
  • Torrao L, Machado R, Pires N, Palma N, Bonifacio MJ, Wright LC, Soares-da-Silva P. (2011) Effects of eslicarbazepine acetate, eslicarbazepine, carbamazepine and oxcarbazepine in the 6-HZ psychomotor seizure model in the mice. Epilepsia52:118119.
  • Volosov A, Xiaodong S, Perucca E, Yagen B, Sintov A, Bialer M. (1999) Enantioselective pharmacokinetics of 10-hydroxycarbazepine after oral administration of oxcarbazepine to healthy Chinese subjects. Clin Pharmacol Ther66:547553.